GPR88 agonists (Domain Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGPR88 agonists (Domain Therapeutics)
Drug Alias NameGPCR modulators (Domain Therapeutics)GPR88 modulators (Domain Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProbable G-protein coupled receptor 88 agonists
TargetsProbable G-protein coupled receptor 88
Therapy Area/IndicationsSchizophreniaAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDomain Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDomain Therapeutics SA
Active IndicationsN/A
Inactive IndicationsSchizophreniaAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN/A
Related LinksN/A